Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» congenital adrenal hyperplasia
congenital adrenal hyperplasia
Neurocrine’s hopes for hyperplasia blockbuster a step closer after phase 3 win
Neurocrine’s hopes for hyperplasia blockbuster a step closer after phase 3 win
Fierce Biotech
Neurocrine Biosciences
crinecerfont
clinical trials
congenital adrenal hyperplasia
Flag link:
Spruce's Drug Candidate Reduces Elevated Hormones in Classic CAH Patients
Spruce's Drug Candidate Reduces Elevated Hormones in Classic CAH Patients
BioSpace
Spruce Biosciences
clinical trials
congenital adrenal hyperplasia
tildacerfont
Flag link:
Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug
Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug
Xconomy
Spruce Biosciences
congenital adrenal hyperplasia
Flag link:
Armed with a batch of positive biomarker data, a rare disease player reaps $88M for the next big push in the clinic
Armed with a batch of positive biomarker data, a rare disease player reaps $88M for the next big push in the clinic
Endpoints
Spruce
tildacerfont
congenital adrenal hyperplasia
Flag link:
Neurocrine hits the brakes on its genetic disease drug
Neurocrine hits the brakes on its genetic disease drug
Fierce Biotech
Neurocrine
NBI-77860
congenital adrenal hyperplasia
Flag link: